MRI-guided Bone Marrow Biopsies of Advanced CaP Patients
- This study involves a one-time, MRI-guided bone marrow biopsy. Prior to this
procedure, patients will need to have a bone scan performed within the last three
months and a PSA blood test drawn within one month of registration to the study.
- Patients are also required to participate in the DFCI research study "Collection of
Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To compare the yield of detecting metastatic prostate cancer tissue using MRI-guided bone marrow needle biopsies to that of historical controls obtained through unguided biopsies.
Mary-Ellen Taplin, MD
Dana-Farber Cancer Institute
United States: Institutional Review Board
|Dana-Farber Cancer Institute||Boston, Massachusetts 02115|